Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Glioblastoma 4Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Gliosarcoma 3Fallopian Tube Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Rectal Neoplasms 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Glioma 2Colorectal Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Oropharyngeal Neoplasms 1Oligodendroglioma 1

Interventions

Temozolomide 7Magnetic Resonance Spectroscopy 7X-Rays 5Phantoms, Imaging 5Bevacizumab 5Specimen Handling 4Nuclear Medicine Department, Hospital 4Carboplatin 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2Vemurafenib 2Lapatinib 2LY3023414 2Everolimus 2Etoposide 2Erlotinib Hydrochloride 2veliparib 1pomalidomide 1poly ICLC 1picropodophyllin 1marizomib 1imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ependymoma × veliparib × Clear all
NCT01026493 2017-07-02

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 1/2 Completed
257 enrolled 16 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡